losartan has been researched along with Actinic Reticuloid Syndrome in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nakao, S | 1 |
Hatahira, H | 1 |
Sasaoka, S | 1 |
Hasegawa, S | 1 |
Motooka, Y | 1 |
Ueda, N | 1 |
Abe, J | 1 |
Fukuda, A | 1 |
Naganuma, M | 1 |
Kanoh, H | 1 |
Seishima, M | 1 |
Ishiguro, M | 1 |
Kinosada, Y | 1 |
Nakamura, M | 1 |
1 other study available for losartan and Actinic Reticuloid Syndrome
Article | Year |
---|---|
Evaluation of Drug-Induced Photosensitivity Using the Japanese Adverse Drug Event Report (JADER) Database.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Angiotensin II | 2017 |